Zobrazeno 1 - 10
of 163
pro vyhledávání: '"Pierre, Biron"'
Publikováno v:
Fundamental & Clinical Pharmacology. 36:1125-1127
A fifth vaccine against Covid-19, NVX-CoV2373 Nuvavoxid® (Novavax), a protein-based adjuvanted vaccine, was recently marketed in Europe. The main clinical trial before marketing concluded to a 'vaccine efficacy' of 89.7% without talking about other
Autor:
Olfa Derbel, Pierre Etienne Heudel, Claire Cropet, Pierre Meeus, Gualter Vaz, Pierre Biron, Philippe Cassier, Anne-Valérie Decouvelaere, Dominique Ranchere-Vince, Olivier Collard, Eric De Laroche, Philippe Thiesse, Fadila Farsi, Dominic Cellier, François-Noel Gilly, Jean-Yves Blay, Isabelle Ray-Coquard
Publikováno v:
PLoS ONE, Vol 12, Iss 2, p e0158406 (2017)
PURPOSE:The outcome of sarcoma has been suggested in retrospective and non-exhaustive studies to be better through management by a multidisciplinary team of experts and adherence to clinical practice guidelines (CPGs). The aim of this prospective and
Externí odkaz:
https://doaj.org/article/e4b88e6c08cb4af783fd564dbe17ff45
Autor:
Lionel Perrier, Morgane Plantier, Nathalie Havet, Thierry Durand, Nicolas Caquot, Camille Amaz, Irène Philip, Pierre Biron
Publikováno v:
International Journal of Integrated Care, Vol 15, Iss 7 (2015)
Externí odkaz:
https://doaj.org/article/6ac5b8be4d3545e1b1d4d4e4fe4794fe
Publikováno v:
Fundamental & Clinical Pharmacology
Several vaccines are being developed as part of the COVID‐19 pandemic. The results of clinical trials for these vaccines were published with efficacy values of more than 90%, using mainly relative risk (RR). In this paper, we decided to reanalyse t
Autor:
Stefan Topolski, Adam C Urato, Robert Cook-Deegan, Lisa Bero, Laura S Boylan, Barbara Mintzes, Lisa Cosgrove, Jay Siwek, Eileen Fingerman, Rafael Gracia, Jon Jureidini, Lusy Paulyna Orellana Navarrete, Florian Naudet, Peter C Gøtzsche, Cindy Farquhar, Vera Sharav, Alain Braillon, Joel Lexchin, Jeanne Lenzer, Andrew Kotaska, David U. Himmelstein, Adam G Elshaug, David O. Antonuccio, Alan Cassels, Iona Heath, Geneviève Rail, James M. Brophy, Alexander C. Tsai, Elia Abi-Jaoude, Richard G. Roberts, Daniel M Fatovich, Teppo L. N. Järvinen, Pierre Biron, Susan Levenstein, Shannon Brownlee, Harrison Alter, Cynthia A Pearson, John Abramson, Jerome R. Hoffman, Thomas Kuehlein, Juan Gérvas, Richard A. Deyo, Naman Shah, Manon Niquette, Louise B Andrew, Luca De Fiore
Publikováno v:
Obstetrics & Gynecology. 134:1115-1117
Autor:
Anne-Valérie Decouvelaere, Olfa Derbel, François-Noël Gilly, Gualter Vaz, Eric De Laroche, Jean-Yves Blay, Pierre Meeus, Philippe A. Cassier, Philippe Thiesse, Dominique Ranchère-Vince, Claire Cropet, Dominic Cellier, Pierre Heudel, Fadila Farsi, Pierre Biron, Isabelle Ray-Coquard, Olivier Collard
Publikováno v:
PLoS ONE
PLoS ONE, Vol 12, Iss 2, p e0158406 (2017)
PLoS ONE, Vol 12, Iss 2, p e0158406 (2017)
Purpose The outcome of sarcoma has been suggested in retrospective and non-exhaustive studies to be better through management by a multidisciplinary team of experts and adherence to clinical practice guidelines (CPGs). The aim of this prospective and
Autor:
Lionel Perrier, Nathalie Havet, Nicolas Caquot, Camille Amaz, Morgane Plantier, Thierry Durand, Irène Philip, Pierre Biron
Publikováno v:
International Journal of Medical Informatics
International Journal of Medical Informatics, 2017, 98, pp. 47-55. ⟨10.1016/j.ijmedinf.2016.12.002⟩
International Journal of Medical Informatics, Elsevier, 2017, 98, pp. 47-55. ⟨10.1016/j.ijmedinf.2016.12.002⟩
International Journal of Medical Informatics, 2017, 98, pp. 47-55. ⟨10.1016/j.ijmedinf.2016.12.002⟩
International Journal of Medical Informatics, Elsevier, 2017, 98, pp. 47-55. ⟨10.1016/j.ijmedinf.2016.12.002⟩
Background Electronic health records (EHR) are increasingly being adopted by healthcare systems worldwide. In France, the “Hopital numerique 2012–2017” program was implemented as part of a strategic plan to modernize health information technolo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b14106fd86bd4c474251bbe36b5f117e
https://shs.hal.science/halshs-01421101
https://shs.hal.science/halshs-01421101
Autor:
Morgane Plantier, Irène Philip, Nathalie Havet, Pierre Biron, Camille Amaz, Nicolas Caquot, Thierry Durand, Lionel Perrier
Publikováno v:
International Journal of Medical Informatics
International Journal of Medical Informatics, Elsevier, 2017, 102, pp. 156-165. ⟨10.1016/j.ijmedinf.2017.04.002⟩
International Journal of Medical Informatics, 2017, 102, pp. 156-165. ⟨10.1016/j.ijmedinf.2017.04.002⟩
International Journal of Medical Informatics, Elsevier, 2017, 102, pp. 156-165. ⟨10.1016/j.ijmedinf.2017.04.002⟩
International Journal of Medical Informatics, 2017, 102, pp. 156-165. ⟨10.1016/j.ijmedinf.2017.04.002⟩
Background Electronic health records (EHR) are increasingly being adopted by healthcare systems worldwide. In France, the “Hopital numerique 2012–2017” program was implemented as part of a strategic plan to modernize health information technolo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a9f58e19947c13165b63aca5437f9aa
https://halshs.archives-ouvertes.fr/halshs-01619178
https://halshs.archives-ouvertes.fr/halshs-01619178
Autor:
Catherine Chassagne-Clément, Catherine Sebban, Pierre Faurie, Philippe Rey, Hervé Ghesquières, Amine Belhabri, Celine Segura-Ferlay, Emmanuelle Nicolas-Virelizier, Thérèse Gargi, Pierre Biron, Sylvie Chabaud
Publikováno v:
Hematological Oncology. 33:1-8
Rituximab was approved in France in 2004, following randomized trials that demonstrated efficacy in newly diagnosed high tumour burden follicular lymphoma (FL). This retrospective study compared the management and outcome of FL in unselected patients
Autor:
Inthidar Labidi Galy, Catherine Sebban, Jean-Yves Blay, Olivier Tredan, Thomas Bachelot, Christophe Borg, Gilles Clapisson, Irène Philip, Claire Cropet, David Pérol, Isabelle Ray-Coquard, Pierre Biron, Sylvie Chabaud, Christine Ménétrier-Caux, Philippe A. Cassier, Christophe Caux, Julien Péron
Publikováno v:
European Journal of Cancer
European Journal of Cancer, 2013, 49 (5), pp.1080-9. ⟨10.1016/j.ejca.2012.11.003⟩
European Journal of Cancer, Elsevier, 2013, 49 (5), pp.1080-9. ⟨10.1016/j.ejca.2012.11.003⟩
European Journal of Cancer, 2013, 49 (5), pp.1080-9. ⟨10.1016/j.ejca.2012.11.003⟩
European Journal of Cancer, Elsevier, 2013, 49 (5), pp.1080-9. ⟨10.1016/j.ejca.2012.11.003⟩
International audience; BACKGROUND: Cancer patients with CD4 lymphopenia have an increased risk of severe toxicity after administration of cytotoxic chemotherapy. The impact of CD4 lymphopenia on long term overall survival (OS) of cancer patients was